Boon, Eline
79  results:
Search for persons X
?
2

Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-..:

Verhoeff, Sarah R. ; van Es, Suzanne C. ; Boon, Eline...
European Journal of Nuclear Medicine and Molecular Imaging.  46 (2019)  9 - p. 1931-1939 , 2019
 
?
3

A clinicopathological study and prognostic factor analysis ..:

Boon, Eline ; Bel, Miranda ; van Boxtel, Wim...
International Journal of Cancer.  143 (2018)  4 - p. 758-766 , 2018
 
?
10

RAS and BRAF mutations in cell-free DNA are predictive for ..:

van Helden, Erik J ; Angus, Lindsay ; Menke-van der Houven van Oordt, C Willemien...
van Helden , E J , Angus , L , Menke-van der Houven van Oordt , C W , Heideman , D A M , Boon , E , van Es , S C , Radema , S A , van Herpen , C M L , de Groot , D J A , de Vries , E G E , Jansen , M P H M , Sleijfer , S & Verheul , H M W 2019 , ' RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer ' , Molecular oncology , vol. 13 , no. 11 , pp. 2361-2374 . https://doi.org/10.1002/1878-0261.12550.  , 2019
 
?
 
?
13

Decalcification of Breast Cancer Bone Metastases With EDTA ..:

van Es, Suzanne C ; van der Vegt, Bert ; Bensch, Frederike...
https://research.rug.nl/en/publications/27a9ca08-daeb-4399-85bb-8fee5ecee92d.  , 2019
 
?
14

Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FD..:

Verhoeff, Sarah R ; van Es, Suzanne C ; Boon, Eline...
https://research.rug.nl/en/publications/cf169f88-d2c7-48b9-9e87-62ee181ee431.  , 2019
 
?
15

Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-..:

Verhoeff, Sarah R ; van Es, Suzanne C ; Boon, Eline...
Verhoeff , S R , van Es , S C , Boon , E , van Helden , E , Angus , L , Elias , S G , Oosting , S F , Aarntzen , E H , Brouwers , A H , Kwee , T C , Heskamp , S , Hoekstra , O S , Verheul , H , van der Veldt , A A M , de Vries , E G E , Boerman , O C , van der Graaf , W T A , Oyen , W J G & van Herpen , C M L 2019 , ' Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma ' , European Journal of Nuclear Medicine and Molecular Imaging , vol. 46 , no. 9 , pp. 1931-1939 . https://doi.org/10.1007/s00259-019-04358-9.  , 2019
 
1-15